Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Cardiometabolic sex differences in adults born small for gestational age
Indexado
WoS WOS:001102542000001
Scopus SCOPUS_ID:85176273860
DOI 10.3389/FCVM.2023.1223928
Año 2023
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Aim: This study aimed to assess the cardiometabolic sex similarities and differences in adults born small for gestational age. Methods: This study was an ambispective cohort study from a birth registry in Barcelona, Spain, including 523 adult participants (20–40 years-old) subdivided as born small for gestational age (SGA, if birth weight <10th centile) or adequate fetal growth for gestational age (AGA). Cardiometabolic health was assessed by echocardiography, electrocardiogram, blood pressure measurement, vascular ultrasound, anthropometric measurements, and serum glycemia and lipid profile. Stratified analyses by sex were performed by estimation of adjusted absolute difference (AAD) using inverse probability weighting. Results: Compared with AGA, the stratified analyses by sex showed a more pronounced reduction in ejection fraction [AAD: female −1.73 (95% CI −3.2 to −0.28) vs. male −1.33 (−3.19 to 0.52)] and increment in heart rate [female 3.04 (0.29–5.8) vs. male 2.25 (−0.82 to 5.31)] in SGA females compared with SGA males. In contrast, a more pronounced reduction in PR interval [female −1.36 (−6.15 to 3.42) vs. male −6.61 (−11.67 to −1.54)] and an increase in systolic blood pressure [female 0.06 (−2.7 to 2.81) vs. male 2.71 (−0.48 to 5.9)] and central-to-peripheral fat ratio [female 0.05 (−0.03 to 0.12) vs. male 0.40 (0.17–0.62)] were mainly observed in SGA male compared with SGA female. Conclusions: Sex differences were observed in the effect of SGA on cardiometabolic endpoints with female being more prone to cardiac dysfunction and male to electrocardiographic, vascular, and metabolic changes. Future research including sex-stratification data is warranted.

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Cardiac & Cardiovascular Systems
Cardiac & Cardiovascular System
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Rodríguez-López, Mérida - Universitat de Barcelona - España
Universidad Icesi - Colombia
Fundación Valle del Lili - Colombia
Univ Barcelona - España
Univ Icesi - Colombia
Fdn Valle Lili - Colombia
2 Sepúlveda-Martínez, Álvaro Hombre Universitat de Barcelona - España
Hospital Clínico Universidad de Chile - Chile
Univ Barcelona - España
Hosp Clin Univ Chile - Chile
3 Bernardino, Gabriel Hombre Universitat Pompeu Fabra Barcelona - España
Univ Pompeu Fabra - España
4 Crovetto, F. Mujer Universitat de Barcelona - España
Univ Barcelona - España
5 Pajuelo, Carolina Mujer Universitat de Barcelona - España
Univ Barcelona - España
6 Sitges, Marta Mujer Universitat de Barcelona - España
Institut d'Investigacions Biomèdiques August Pi i Sunyer - IDIBAPS - España
Univ Barcelona - España
Inst Invest Biomed August Pi i Sunyer - España
7 Bijnens, Bart H. Hombre Institut d'Investigacions Biomèdiques August Pi i Sunyer - IDIBAPS - España
Institució Catalana de Recerca i Estudis Avançats - España
Inst Invest Biomed August Pi i Sunyer - España
Catalan Inst Res & Adv Studies ICREA - España
Universitat de Barcelona - España
8 Gratacos, Eduardo Hombre Universitat de Barcelona - España
Institut d'Investigacions Biomèdiques August Pi i Sunyer - IDIBAPS - España
Univ Barcelona - España
Inst Invest Biomed August Pi i Sunyer - España
9 Crispi, F. Mujer Universitat de Barcelona - España
Institut d'Investigacions Biomèdiques August Pi i Sunyer - IDIBAPS - España
Univ Barcelona - España
Inst Invest Biomed August Pi i Sunyer - España

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
European Commission
Instituto de Salud Carlos III
"la Caixa" Foundation
Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK)
Agència de Gestió d'Ajuts Universitaris i de Recerca
Erasmus+ Programme of the European Union
commission
Centro de Investigacion Biomedica en Red de Enfermedades Raras
la Caixa” Foundation
European Union Horizon 2020 Programme for Research and Innovation
Cerebra Foundation
Fundació Jesús Serra of the Grupo Catalana Occidente for the Fundació Jesús Serra
Fundaci Jess Serra of the Grupo Catalana Occidente
European Union (Spain)
This project was partially funded with the support of the Erasmus+ Programme of the European Union (Framework Agreement number: 2013-0040) and the European Union Horizon 2020 Programme for Research and Innovation, under grant agreement No. 642676 (CardioFu

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
This project was partially funded with the support of the Erasmus+ Programme of the European Union (Framework Agreement number: 2013-0040) and the European Union Horizon 2020 Programme for Research and Innovation, under grant agreement No. 642676 (CardioFunXion). This publication reflects the views only of the authors, and the Commission cannot be held responsible for any use which may be made of the information contained therein. Additionally, the research leading to these results received funding from the “la Caixa” Foundation under grant agreement LCF/PR/GN18/10310003 (Spain) and the Instituto de Salud Carlos III through the projects (INT21/00027, PI18/00073, and PI14/00226), and was co-funded by the European Union (Spain), Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK), the Centro de Investigación Biomédica en Red de Enfermedades Raras (ERPR04G719/2016) (Spain), and Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) under grant 2017 SGR No. 1531) (Spain). Lastly, we would like to thank the Fundació Jesús Serra of the Grupo Catalana Occidente for the Fundació Jesús Serra Research Awards in the Clinical category granted to the researcher Fàtima Crispi in its 4th edition for the project titled “Cardiovascular prevention from fetal life: benefits of Mediterranean diet during gestation”.
This project was partially funded with the support of the Erasmus+ Programme of the European Union (Framework Agreement number: 2013-0040) and the European Union Horizon 2020 Programme for Research and Innovation, under grant agreement No. 642676 (CardioFunXion). This publication reflects the views only of the authors, and the Commission cannot be held responsible for any use which may be made of the information contained therein. Additionally, the research leading to these results received funding from the “la Caixa” Foundation under grant agreement LCF/PR/GN18/10310003 (Spain) and the Instituto de Salud Carlos III through the projects (INT21/00027, PI18/00073, and PI14/00226), and was co-funded by the European Union (Spain), Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK), the Centro de Investigación Biomédica en Red de Enfermedades Raras (ERPR04G719/2016) (Spain), and Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) under grant 2017 SGR No. 1531) (Spain). Lastly, we would like to thank the Fundació Jesús Serra of the Grupo Catalana Occidente for the Fundació Jesús Serra Research Awards in the Clinical category granted to the researcher Fàtima Crispi in its 4th edition for the project titled “Cardiovascular prevention from fetal life: benefits of Mediterranean diet during gestation”.
This project was partially funded with the support of the Erasmus+ Programme of the European Union (Framework Agreement number: 2013-0040) and the European Union Horizon 2020 Programme for Research and Innovation, under grant agreement No. 642676 (Cardio FunXion). This publication reflects the views only of the authors, and the Commission cannot be held responsible for any use which may be made of he information contained therein. Additionally, the research leading to these results received funding from the"la Caixa"Foundation under grant agreement LCF/PR/GN18/10310003(Spain) and the Instituto de Salud Carlos III through the projects(INT21/00027, PI18/00073, and PI14/00226), and was co-funded by the European Union (Spain), Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK), the Centro deInvestigacion Biomedica en Red de Enfermedades Raras(ERPR04G719/2016) (Spain), and Agencia de Gestio d'AjutsUniversitaris i de Recerca (AGAUR) under grant 2017 SGR No.1531) (Spain). Lastly, we would like to thank the Fundacio JesusSerra of the Grupo Catalana Occidente for the Fundacio JesusSerra Research Awards in the Clinical category granted to the researcher Fatima Crispi in its 4th edition for the project titled"Cardiovascular prevention from fetal life: benefits of Mediterranean diet during gestation"r This project was partially funded with the support of the Erasmus+ Programme of the European Union (Framework Agreement number: 2013-0040) and the European Union Horizon 2020 Programme for Research and Innovation, under grant agreement No. 642676 (CardioFunXion). This publication reflects the views only of the authors, and the Commission cannot be held responsible for any use which may be made of the information contained therein. Additionally, the research leading to these results received funding from the "la Caixa" Foundation under grant agreement LCF/PR/GN18/10310003 (Spain) and the Instituto de Salud Carlos III through the projects (INT21/00027, PI18/00073, and PI14/00226), and was co-funded by the European Union (Spain), Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK), the Centro de Investigacion Biomedica en Red de Enfermedades Raras (ERPR04G719/2016) (Spain), and Agencia de Gestio d & apos;Ajuts Universitaris i de Recerca (AGAUR) under grant 2017 SGR No. 1531) (Spain). Lastly, we would like to thank the Fundacio Jesus Serra of the Grupo Catalana Occidente for the Fundacio Jesus Serra Research Awards in the Clinical category granted to the researcher Fatima Crispi in its 4th edition for the project titled "Cardiovascular prevention from fetal life: benefits of Mediterranean diet during gestation".

Muestra la fuente de financiamiento declarada en la publicación.